Weave Bio Establishes Inaugural Strategic Advisory Board to Shape the Future of AI-Driven Regulatory Science

SAN FRANCISCO--(BUSINESS WIRE)---- $TMV #AIinPharma--Weave Bio, the leader in AI-native regulatory automation, today announced the formation of its inaugural Strategic Advisory Board (SAB). Bringing together senior executives and thought leaders with expertise spanning pharma regulatory strategy and operations, health authority policy and practice, capital markets, and academic research, the SAB will serve as a strategic forum to guide the evolution of the Weave Platform and advance the responsible adoption of AI a.

Business Wire • Mar 25, 2026

This legendary investor has been shorting Treasury bonds. Here's how to bet with him — without going broke.

Stanley Druckenmiller's bet against America's debt is no ordinary trade.

Market Watch • Jul 15, 2025

Fed Easing Could Heat These ETFs This Summer

May's inflation data could bring Treasury bulls back into the fray. If the Fed has the signal they need to start easing monetary policy, then it could bring up the Direxion Daily 20+ Year Treasury Bull 3X Shares (TMF) and the Direxion Daily 7-10 Year Treasury Bull 3X Shares (TYD).

ETF Trends • Jul 7, 2025

TMV: Bear Bet On Structural Financial Conditions

TMV offers a high-risk, high-reward way to speculate on rising long-term Treasury yields, but is only suitable for short-term, event-driven trades. Concerns about the USD's reserve currency status, driven by isolationism policy, could pressure long-duration Treasuries. Leveraged ETFs like TMV suffer from value erosion and compounding risk, making them unsuitable for buy-and-hold investors or those unfamiliar with their mechanics.

Seeking Alpha • Jun 6, 2025

Heavy Market Volatility Creates Opportunities for Treasuries

Tariffs are roiling the major stock market indexes with volatility. So investors have been pouring into bonds to escape the turmoil.

ETF Trends • Apr 16, 2025

3 ETFs to Watch as Yields Continue to Creep Higher

Inflation appears to be stubborn and persistent. That's providing entry points for three Direxion inverse ETFs for traders looking to capitalize on rising yields.

ETF Trends • Jan 15, 2025

ETF Strategies to Play Amid Rising Treasury Yields

These ETF strategies may safeguard your portfolio amid rising treasury yields.

Zacks Investment Research • Jan 14, 2025

Inverse Treasury ETFs Rallying on Spike in Yields

The spike in yields has led to a surge in ETFs that bet against U.S. Treasury bonds.

Zacks Investment Research • Jan 8, 2025

TMV: A Levered Play Against Treasuries

TMV offers leveraged inverse exposure to long-term Treasury bonds, aiming for three times the opposite daily performance of the ICE U.S. Treasury 20+ Year Bond Index. The fund's 3x leverage allows for significant short-term gains, but also magnifies losses and requires hands-on management due to volatility decay. TMV is a potential hedging tool for those with large long positions in Treasury bonds, but its high expense ratio and complex structure are drawbacks.

Seeking Alpha • Dec 8, 2024

Turning Bullish Once More In TMV

Initially rated Direxion Daily 20+ Year Treasury Bear 3X Shares a 'Buy' in 2022, yielding 65% and 51% returns since commentaries, but downgraded to 'Hold' in 2023 due to time decay risks. Leveraged funds like TMV suffer from significant time decay in consolidating markets, requiring active trading rather than holding. TBF's recent MACD buy signal and golden cross indicate an upcoming bullish trend, prompting an upgrade of TMV back to 'Buy'.

Seeking Alpha • Nov 22, 2024